Personal Capital Advisors’s CervoMed CRVO Stock Holding History

Personal Capital Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-133	Closed	-$8K	–	460
2020 Q3	$8K	Buy	+133	New	+$10.1K	﹤0.01%	417

Other funds holding CRVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Personal Capital Advisors's CRVO Position: Q4 2020 in Review

Personal Capital Advisors sold out of CervoMed (CRVO) in Q4 2020, closing a stake of 133 shares — an estimated $8K sold.

Personal Capital Advisors first reported a position in CRVO in Q3 2020 and held it in 1 quarter. The position peaked at $8K in Q3 2020. 21 funds tracked by Wall St. Rank hold CRVO as of Q4 2020.

Personal Capital Advisors reported no remaining CervoMed position as of Q4 2020 after selling out during the quarter.
Personal Capital Advisors sold 133 CervoMed shares in Q4 2020, an estimated $8K.
Personal Capital Advisors first reported a position in CervoMed in Q3 2020 and held it in 1 quarter.
Personal Capital Advisors's CervoMed position peaked at $8K in Q3 2020.
21 funds tracked by Wall St. Rank held CervoMed as of Q4 2020.

Based on Personal Capital Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.